One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America

Journal Title: Jornal de Pediatria - Year 2017, Vol 93, Issue 5

Abstract

Objective This study aims to describe real world palivizumab use and effectiveness in high-risk Latin American infants and young children. Method Prospective, multicenter observational study with infants at risk for severe RSV infection who received palivizumab according to routine clinical practice. Subjects were followed for one year with monthly visits after the first dose of palivizumab. An infant was considered adherent if receiving all the expected injections or five or fewer injections within appropriate inter-dose intervals. Annual incidence rates and risk factors of lower respiratory tract infection (LRTI) hospitalization were determined through Poisson regression models (α=0.05). Results The study enrolled 458 children from seven countries in Latin America, from February 2011 to September 2012. The majority (98%) were born <36 weeks gestation. Overall, patients received 83.7% of their expected injections and 86.7% completed one year of follow-up. Of the 61 LRTI hospitalizations, 12 episodes were due to RSV infection. The RSV-associated hospitalization rate was 2.9 per 100 patient-years. Bronchopulmonary dysplasia was identified as an independent risk factor for LRTI hospitalization. A total of 1165 adverse events were recorded during one year of follow-up. One hundred and two patients (22.3%) had a total of 135 serious adverse events, but no events were considered to be related to palivizumab. Conclusions The rate of RSV hospitalization in high-risk infants in Latin America was low and aligned with those observed in randomized control trials and observational studies. Palivizumab prophylaxis appeared effective and had a good safety profile in this population.

Authors and Affiliations

Gabriela Bugarin

Keywords

Related Articles

Evaluation of a neonatal screening program for sickle-cell disease

Objective Evaluate the Neonatal Screening Program of the Health Secretariat of the State of Santa Catarina for sickle-cell disease, from January 2003 to December 2012, regarding program coverage and disease frequency. M...

Increased ApoB/ApoA1 ratio is associated with excess weight, body adiposity, and altered lipid profile in children

Objective To investigate ApoB/ApoA1 ratio and its association with cardiovascular risk factors in children. Methods Cross-sectional study with 258 children aged 8 and 9 years old, enrolled in all urban schools in the ci...

Impulse oscillometry and obesity in children

Objective To compare impulse oscillometry system parameters of normal-weight children with overweight and obese children. Method All participants were submitted to the evaluation of lung function (spirometry and impulse...

Nutritional quality of dietary patterns of children: are there differences inside and outside school?

Objectives To describe the dietary patterns of children inside and outside school and investigate their associations with sociodemographic factors and nutritional status. Methods This was a multicenter cross-sectional s...

Early neonatal deaths associated with perinatal asphyxia in infants ≥2500g in Brazil

Objective To assess the annual burden of early neonatal deaths associated with perinatal asphyxia in infants weighing ≥2500g in Brazil from 2005 to 2010. Methods The population study enrolled all live births of infants...

Download PDF file
  • EP ID EP503536
  • DOI 10.1016/j.jped.2016.11.006
  • Views 70
  • Downloads 0

How To Cite

Gabriela Bugarin (2017). One-year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America. Jornal de Pediatria, 93(5), 467-474. https://europub.co.uk./articles/-A-503536